Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/822
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGustiananda, Marsia-
dc.contributor.authorPurnama, Shawn Tjahaja-
dc.contributor.authorSiswanto, Melinda-
dc.date.accessioned2023-09-30T00:53:37Z-
dc.date.available2023-09-30T00:53:37Z-
dc.date.issued2019-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/822-
dc.description.abstractT cells are the primary effector cells of tumor immunity. T cells recognized peptides derived from tumor antigens wich is presented as a complex with HLA (histocompatibility leukocyte antigen - HLA) on the surface of target cells. HLA-A*24:07 is the major HLA alleles in Indonesia. HLA A*24:07 is considered unique and not a member of the HLA A*24 supertype, which is represented by HLA A*24:02. The two molecules, A*24:02 and A*24:07, share high homology except for one amino acid residue number 70. Residue number 70 in A*24:02 is H and in A*24:07 is Q. This residue happens to be in the peptide binding groove of the HLA allele, and affecting at least 3 out of 6 peptide binding pockets. HLA-A*24:07 is a less characterized allele, and at the moment, there is only one T-cell epitopes reported to be restricted by this HLA allele (IEDB website). The paper will present the peptide binding motif of HLA A*24:07, the benchmark of online T cell epitope prediction server, and the use of prediction server to predict peptide derived from cancer antigens that will bind to HLA A*24:07en_US
dc.language.isoenen_US
dc.publisherDepartment of Biomedicine, School of Life Sciences, Indonesia International Institute for Life Sciencesen_US
dc.subjectT cellen_US
dc.subjectCanceren_US
dc.subjectHLA A*24:07en_US
dc.titleT cell epitope prediction of cancer antigens restricted by HLA A*24:07en_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
INCOB2019_HLAA2407.pdf1.62 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.